The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
993
January 31, 1997
View Complete Issue         Table of Contents 2019 
Betaine for Homocystinuria
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Betaine for Homocystinuria
January 31, 1997 (Issue: 993)
Betaine (Cystadane - Orphan Medical), an orphan drug, has recently been marketed for treatment of homocystinuria, a genetic disorder. Patients with homocystinuria frequently have premature atherosclerosis and thromboembolism, and may also have ...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Betaine for Homocystinuria
Article code: 993c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.